Page 6 - Use Authorisation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

By Syndicated Content May 18, 2021 | 12:16 AM ZURICH (Reuters) – Roche’s cobas SARS-CoV-2 Test has received U.S. authorisation for testing individuals without symptoms or reasons to suspect a COVID-19 infection, the Swiss drugmaker said on Tuesday. “The high-throughput, highly sensitive cobas SARS-CoV-2 Test under FDA Emergency Use Authorisation can now be used to test individual or pooled samples from people without symptoms or other reasons to suspect COVID-19,” Roche said in a statement. (Reporting by Brenna Hughes Neghaiwi; Editing by Riham Alkousaa) '); } return f...

• Any COVID-19 vaccine not through government channels should be considered as counterfeit, say experts • Guild of Medical Directors, security experts call for robust surveillance to check fake COVID-19 vaccines • Want NAFDAC to test all batches of COVID-19 vaccines Three days after Nigeria began vaccination for coronavirus, there are concerns that fake and illegal COVID-19 vaccines may soon flood the Nigerian market if the Federal Government did not tackle the situation urgently. x The anxiety was heightened, last week, when the global police organi...

The Presidential Task Force (PTF) on COVID-19 says it is expecting three types of vaccines for Nigerians. The federal government has approved Nnamdi

Business Scoop provides news and views on Business and Markets from New Zealand

Investegate announcements from F. Hoffmann-La Roche Ltd, EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19